穿越周期 GSK中国区“新帅”谈如何把握中国市场

国际金融报
24 Oct 2024

降本增效、人事调整、加速本土化成为激烈市场竞争下跨国药企在华发展的关键词。今年5月,跨国药企葛兰素史克(GSK)同样进行了中国区的人事调整。  GSK原中国区总经理齐欣,升任为GSK大中华和洲际区域(GCI)副总裁兼疫苗业务负责人,公司原副总裁兼台湾地区总经理余慧明“接棒”,并于7月1日起到任。余慧明也是继齐欣后GSK中国区的第二位女性本土总经理。  截至目前,余慧明上任已百天有余。谈及上任以来的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10